Benzyl-(1-hydroxy-1-phenylpropan-2-yl)-dimethylazanium

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Benzyl-(1-hydroxy-1-phenylpropan-2-yl)-dimethylazanium
• 化学式: C18H24NO+
• 分子量: 270.4
• InChiKey: GEBWLJOOGXIBCH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• Optically enhanced chiral ionic liquids
  申请人：Armstrong W. Daniel

  公开号：US20060014955A1

  公开（公告）日：2006-01-19

  The invention relates to the use of optically enhanced chiral ionic liquids, particularly for gas chromatography and as a reaction solvent. Specific optically enhanced chiral cationic liquids are described as is a class of optically enhanced chiral anionic liquids.

  本发明涉及使用光学增强手性离子液体，特别是用于气相色谱和反应溶剂。具体描述了光学增强手性阳离子液体，以及一类光学增强手性阴离子液体。
• Novel Method for Preparation of Ammonium Salts of Esomeprazole
  申请人：Bergman Rolf

  公开号：US20090197919A1

  公开（公告）日：2009-08-06

  The present invention relates to a process for the preparation of quartenary ammoniumsalts of esomeprazole. Further, the present invention also relates to the use quartenary ammoniumsalts of esomeprazole for the treatment of gastrointestinal disorders, pharmaceutical compositions containing them as well as the quartenary ammoniumsalts of esomeprazole, as such.

  本发明涉及一种制备左旋埃索美拉唑季铵盐的方法。此外，本发明还涉及使用左旋埃索美拉唑季铵盐治疗胃肠道疾病，含有其作为成分的制药组合物以及左旋埃索美拉唑季铵盐本身。
• OPTICALLY ENHANCED CHIRAL IONIC LIQUIDS
  申请人：Sigma-Aldrich Co.

  公开号：EP1765781A2

  公开（公告）日：2007-03-28
• Optically Enhanced Chiral Ionic Liquids
  申请人：Armstrong Daniel W.

  公开号：US20090145197A1

  公开（公告）日：2009-06-11

  The invention relates to the use of optically enhanced chiral ionic liquids, particularly for gas chromatography and as a reaction solvent. Specific optically enhanced chiral cationic liquids are described as is a class of optically enhanced chiral anionic liquids.
• US7776582B2
  申请人：——

  公开号：US7776582B2

  公开（公告）日：2010-08-17